Complete remission of tumour with interleukin 2 therapy in a patient with non-Hodgkin's lymphoma post allogeneic bone marrow transplant associated with polyclonal T-cell bone marrow lymphocytosis

British Journal of Haematology

Volumn 120, Issue 3, 2003, Pages 523-525

  Kiss, Thomas L ^a   Spaner, David ^b   Daly, Andrew S ^a   Hasegawa, Wanda S ^a   Lipton, Jeffrey H ^a   Messner, Hans A ^a   Chang, Hong ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Bone marrow transplantation; Graff versus lymphoma effect; Interleukin 2; Non Hodgkin's lymphoma; Reactive T cells

Indexed keywords

CD19 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; HYDROXYDAUNORUBICIN; INTERLEUKIN 2; PREDNISOLONE; UNCLASSIFIED DRUG; VINCRISTINE SULFATE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; CANCER REGRESSION; CASE REPORT; CELL AGGREGATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; DISEASE COURSE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOMODULATION; LYMPHOCYTOSIS; MALE; NONHODGKIN LYMPHOMA; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; FOLLOW-UP STUDIES; GRAFT VS HOST REACTION; HUMANS; INTERLEUKIN-2; LYMPHOCYTOSIS; LYMPHOMA, SMALL LYMPHOCYTIC; MALE; MIDDLE AGED; RECURRENCE;

EID: 0037326736     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04082.x     Document Type: Article

References (11)

1. Blaise, D. & Maraninchi, D. (1998) Interleukin 2 in the treatment of acute leukemia. Leukemia Research, 22, 1165-1170.
2. Fefer, A., Robinson, N., Benyunes, M.C., Bensinger, W.L., Press, O., Thompson, J.A. & Lindgren, C. (1997) Interleukin 2 therapy after bone marrow or stem cell transplantation for hematologic malignancies. Cancer Journal from Scientific American, 3, s48-s53.
3. Lopez-Jimenez, J., Perez-Oteyza, J., Munoz, A., Parra, C., Villalon, L., Ramos, P., Maldonado, M., Carcia-Larana, J., Otheo, E., Roldan, E., Carcia-Avello, A. & Odriozola, J. (1997) Subcutaneous versus intravenous low dose IL2 therapy after autologous transplantation: results of a prospective, non randomized study. Bone Marrow Transplantation, 19, 429-434.
4. Massumoto, C., Benyunes, M.C., Sale, G., Beauchamp, M., York, A., Thompson, J.A., Buckner, C.D. & Fefer, A. (1996) Close simulation of acute graft versus host disease by interleukin 2 administered after autologous bone marrow transplantation for hematologic malignancy. Bone Marrow Transplantation, 17, 351-356.
5. Robinson, N., Benyunes, M.C., Thomspon, J.A., York, A., Petersdorf, S., Pres, O., Lindgren, C., Chauncey, T., Buckner, C.D., Bensinger, W.I., Applebaum, E.R. & Fefer, A. (1997) Interleukin 2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study. Bone Marrow Transplantation, 19, 435-442.
6. Schimmer, A.D., Jamal, S., Messner, H., Keating, A., Meharchand, J., Huebsch, L., Walker, I., Berger, A. & Glucks, S.A. (2000) Allogeneic or autologous bone marrow transplantation for non Hodgkins lymphoma (NHL): results of a provincial strategy. Bone Marrow Transplantation, 26, 859-864.
7. Shaffer, L., Giralt, S., Champlin, R. & Chan, K.W. (1995) Treatment of leukemia relapse after bone marrow transplantation with interferon alpha and interleukin 2. Bone Marrow Transplantation, 15, 317-319.
8. Slavin, S. & Nagler, A. (1997) Cytokine mediated immunotherapy following autologous bone marrow transplantation in lymphoma and evidence of Interleukin 2 induced immunomodulation in allogeneic transplants. Cancer Journal from Scientific American, 3, s59-s67.
9. Slavin, S., Naparstek, E., Nagler, A., Ackerstein, A., Samuel, S., Kapelushnik, J., Brautbar, C. & Or. R. (1996) Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin 2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood, 87, 2195-2204.
10. Van Besien, K., Margolin, K., Champlin, R. & Forman, S. (1997) Activity of Interleukin 2 in non Hodgkins lymphoma following transplantation of Interleukin 2 activated autologous bone marrow or stem cells. Cancer Journal from Scientific American, 13, s54-s58.
11. Varadi, G., Ackerstein, A., Ben-Neriah, S. & Nagler, A. (1998) Adoptive cell mediated immunotherapy with interleukin 2 (IL2) for relapsing lymphoblastic crisis following mismatched unrelated bone marrow transplantation in a chronic myelogenous leukemia patient. Bone Marrow Transplantation, 21, 93-96.